Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

CD4+ CD28null T cells are not alloreactive unless stimulated by interleukin-15.

Dedeoglu B, Litjens NHR, Klepper M, Kraaijeveld R, Verschoor W, Baan CC, Betjes MGH.

Am J Transplant. 2018 Feb;18(2):341-350. doi: 10.1111/ajt.14480. Epub 2017 Oct 2.

2.

Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation.

de Graav GN, Hesselink DA, Dieterich M, Kraaijeveld R, Verschoor W, Roelen DL, Litjens NHR, Chong AS, Weimar W, Baan CC.

Front Immunol. 2017 May 31;8:641. doi: 10.3389/fimmu.2017.00641. eCollection 2017.

3.

A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation.

de Graav GN, Baan CC, Clahsen-van Groningen MC, Kraaijeveld R, Dieterich M, Verschoor W, von der Thusen JH, Roelen DL, Cadogan M, van de Wetering J, van Rosmalen J, Weimar W, Hesselink DA.

Transplantation. 2017 Oct;101(10):2571-2581. doi: 10.1097/TP.0000000000001755.

PMID:
28403127
4.

Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation.

Dedeoglu B, de Weerd AE, Huang L, Langerak AW, Dor FJ, Klepper M, Verschoor W, Reijerkerk D, Baan CC, Litjens NH, Betjes MG.

Clin Exp Immunol. 2017 May;188(2):299-310. doi: 10.1111/cei.12934. Epub 2017 Feb 28.

5.

Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs.

Litjens NH, Boer K, Zuijderwijk JM, Klepper M, Peeters AM, Verschoor W, Kraaijeveld R, Betjes MG.

Kidney Int. 2017 May;91(5):1203-1213. doi: 10.1016/j.kint.2016.09.043. Epub 2016 Dec 15.

PMID:
27988212
6.

Allogeneic Mature Human Dendritic Cells Generate Superior Alloreactive Regulatory T Cells in the Presence of IL-15.

Litjens NH, Boer K, Zuijderwijk JM, Klepper M, Peeters AM, Prens EP, Verschoor W, Kraaijeveld R, Ozgur Z, van den Hout-van Vroonhoven MC, van IJcken WF, Baan CC, Betjes MG.

J Immunol. 2015 Jun 1;194(11):5282-93. doi: 10.4049/jimmunol.1402827. Epub 2015 Apr 27.

7.

Monotherapy rapamycin allows an increase of CD4 CD25 FoxP3 T cells in renal recipients.

Hendrikx TK, Velthuis JH, Klepper M, van Gurp E, Geel A, Schoordijk W, Baan CC, Weimar W.

Transpl Int. 2009 Sep;22(9):884-91. doi: 10.1111/j.1432-2277.2009.00890.x. Epub 2009 May 5.

8.

Generation of donor-specific regulatory T-cell function in kidney transplant patients.

Hendrikx TK, van Gurp EA, Sewgobind VD, Mol WM, Schoordijk W, Klepper M, Velthuis JH, Geel A, Ijzermans JN, Weimar W, Baan CC.

Transplantation. 2009 Feb 15;87(3):376-83. doi: 10.1097/TP.0b013e3181901b69.

PMID:
19202442
9.

End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells.

Hendrikx TK, van Gurp EA, Mol WM, Schoordijk W, Sewgobind VD, Ijzermans JN, Weimar W, Baan CC.

Nephrol Dial Transplant. 2009 Jun;24(6):1969-78. doi: 10.1093/ndt/gfp005. Epub 2009 Feb 4.

PMID:
19193737
10.

The effect of the JAK inhibitor CP-690,550 on peripheral immune parameters in stable kidney allograft patients.

van Gurp EA, Schoordijk-Verschoor W, Klepper M, Korevaar SS, Chan G, Weimar W, Baan CC.

Transplantation. 2009 Jan 15;87(1):79-86. doi: 10.1097/TP.0b013e31818bbea7.

PMID:
19136895
11.

IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.

Vitale G, de Herder WW, van Koetsveld PM, Waaijers M, Schoordijk W, Croze E, Colao A, Lamberts SW, Hofland LJ.

Cancer Res. 2006 Jan 1;66(1):554-62.

12.

The effects of renal transplantation on circulating dendritic cells.

Hesselink DA, Vaessen LM, Hop WC, Schoordijk W, Ijzermans JN, Baan CC, Weimar W.

Clin Exp Immunol. 2005 May;140(2):384-93.

Supplemental Content

Loading ...
Support Center